Virus detection and semiquantitation in explanted heart tissues of idiopathic dilated cardiomyopathy adult patients by use of PCR coupled with mass spectrometry analysis

Journal of Clinical Microbiology

Volumn 51, Issue 7, 2013, Pages 2288-2294

  Nguyen, Yohan ^a   Renois, Fanny ^a   Leveque, Nicolas ^a   Giusti, Delphine ^a   Picard Maureau, Marcus ^b   Bruneval, Patrick ^c   Fornes, Paul ^a   Andreoletti, Laurent ^a  

^a REIMS UNIVERSITY HOSPITAL   (France)

^b ABBOTT GMBH AND CO KG   (Germany)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; GENOMIC RNA;

ADULT; AGED; ARTICLE; BIOSENSOR; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; ENTEROVIRUS; FEMALE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN PARVOVIRUS B19; HUMAN TISSUE; MALE; MYOCARDITIS; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VIRUS DETECTION; VIRUS LOAD; COINFECTION; COMPLICATION; ENTEROVIRUS INFECTIONS; EVALUATION STUDY; ISOLATION AND PURIFICATION; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PROCEDURES; TIME; VIROLOGY; YOUNG ADULT;

ENTEROVIRUS; PARVOVIRUS;

ADULT; AGED; CARDIOMYOPATHY, DILATED; COINFECTION; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TIME FACTORS; VIRAL LOAD; YOUNG ADULT;

EID: 84879425225     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00820-13     Document Type: Article

References (34)

1. Andréoletti L, Lévêque N, Boulagnon C, Brasselet C, Fornes P. 2009. Viral causes of human myocarditis. Arch. Cardiovasc. Dis. 102:559-568.
2. Cooper LT, Jr. 2009. Myocarditis. N. Engl. J. Med. 360:1526-1538.
3. Dennert R, Crijns HJ, Heymans S. 2008. Acute viral myocarditis. Eur. Heart J. 29:2073-2082.
4. Dec GW, Jr, Palacios IF, Fallon JT, Aretz HT, Mills J, Lee DC, Johnson RA. 1985. Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N. Engl. J. Med. 312:885-890.
5. Kühl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, Poller W, Kandolf R, Schultheiss H-P. 2005. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with 'idiopathic' left ventricular dysfunction. Circulation 111:887-893.
6. Kühl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, Schultheiss H-P. 2005. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112:1965-1970.
7. Bock C-T, Klingel K, Kandolf R. 2010. Human parvovirus B19-associated myocarditis. N. Engl. J. Med. 362:1248-1249.
8. Leveque N, Renois F, Talmud D, Nguyen Y, Lesaffre F, Boulagnon C, Bruneval P, Fornes P, Andréoletti L. 2012. Quantitative genomic and antigenomic human enterovirus RNA detection in explanted heart tissue samples from patients with end-stage idiopathic dilated cardiomyopathy. J. Clin. Microbiol. 50:3378-3380.
9. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, Levine GN, Narula J, Starling RC, Towbin J, Virmani R. 2007. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J. Am. Coll. Cardiol. 50:1914-1931.
10. Schultheiss H-P, Kühl U, Cooper LT. 2011. The management of myocarditis. Eur. Heart J. 32:2616-2625.
11. Ecker DJ, Sampath R, Massire C, Blyn LB, Hall TA, Eshoo MW, Hofstadler SA. 2008. Ibis T5000: a universal biosensor approach for microbiology. Nat. Rev. Microbiol. 6:553-558.
12. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kühl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A. 2008. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 29:270-276.
13. Ventéo L, Bourlet T, Renois F, Douche-Aourik F, Mosnier J-F, Maison GL, Pluot M, Pozzetto B, Andreoletti L. 2010. Enterovirus-related activation of the cardiomyocyte mitochondrial apoptotic pathway in patients with acute myocarditis. Eur. Heart J. 31:728-736.
14. Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ, Jr, Olsen EG, Schoen FJ. 1987. Myocarditis. A histopathologic definition and classification. Am. J. Cardiovasc. Pathol. 1:3-14.
15. Renois F, Talmud D, Huguenin A, Moutte L, Strady C, Cousson J, Lévêque N, Andréoletti L. 2010. Rapid detection of respiratory tract viral infections and coinfections in patients with influenza-like illnesses by use of reverse transcription-PCR DNA microarray systems. J. Clin. Microbiol. 48:3836-3842.
16. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, Van der Noordaa J. 1990. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 3:495-503.
17. Gravitt PE, Peyton C, Wheeler C, Apple R, Higuchi R, Shah KV. 2003. Reproducibility of HPV 16 and HPV 18 viral load quantitation using Taq-Man real-time PCR assays. J. Virol. Methods 112:23-33.
18. Calvario A, Bozzi A, Scarasciulli M, Ventola C, Seccia R, Stomati D, Brancasi B. 2002. Herpes Consensus PCR test: a useful diagnostic approach to the screening of viral diseases of the central nervous system. J. Clin. Virol. 25:71-78.
19. Candotti D, Etiz N, Parsyan A, Allain J-P. 2004. Identification and characterization of persistent human erythrovirus infection in blood donor samples. J. Virol. 78:12169-12178.
20. Heim A, Ebnet C, Harste G, Pring-Akerblom P. 2003. Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J. Med. Virol. 70:228-239.
21. Leveque N, Van Haecke A, Renois F, Boutolleau D, Talmud D, Andréoletti L. 2011. Rapid virological diagnosis of central nervous system infections by use of a multiplex reverse transcription-PCR DNA microarray. J. Clin. Microbiol. 49:3874-3879.
22. Najioullah F, Thouvenot D, Lina B. 2001. Development of a real-time PCR procedure including an internal control for the measurement of HCMV viral load. J. Virol. Methods 92:55-64.
23. Petitjean J, Vabret A, Dina J, Gouarin S, Freymuth F. 2006. Development and evaluation of a real-time RT-PCR assay on the LightCycler for the rapid detection of enterovirus in cerebrospinal fluid specimens. J. Clin. Virol. 35:278-284.
24. Ecker JA, Massire C, Hall TA, Ranken R, Pennella TT, Agasino Ivy C, Blyn LB, Hofstadler SA, Endy TP, Scott PT, Lindler L, Hamilton T, Gaddy C, Snow K, Pe M, Fishbain J, Craft D, Deye G, Riddell S, Milstrey E, Petruccelli B, Brisse S, Harpin V, Schink A, Ecker DJ, Sampath R, Eshoo MW. 2006. Identification of Acinetobacter species and genotyping of Acinetobacter baumannii by multilocus PCR and mass spectrometry. J. Clin. Microbiol. 44:2921-2932.
25. Andréoletti L, Bourlet T, Moukassa D, Rey L, Hot D, Li Y, Lambert V, Gosselin B, Mosnier JF, Stankowiak C, Wattré P. 2000. Enteroviruses can persist with or without active viral replication in cardiac tissue of patients with end-stage ischemic or dilated cardiomyopathy. J. Infect. Dis. 182:1222-1227.
26. Li Y, Bourlet T, Andréoletti L, Mosnier JF, Peng T, Yang Y, Archard LC, Pozzetto B, Zhang H. 2000. Enteroviral capsid protein VP1 is present in myocardial tissues from some patients with myocarditis or dilated cardiomyopathy. Circulation 101:231-234.
27. Baboonian C, Treasure T. 1997. Meta-analysis of the association of enteroviruses with human heart disease. Heart 78:539-543.
28. Baughman KL. 2006. Diagnosis of myocarditis: death of Dallas criteria. Circulation 113:593-595.
29. Andréoletti L. 2011. Viral myocarditis: physiopathology and diagnosis, p 87-104. In Cihakova D (ed), Myocarditis. InTech, Rijeka, Croatia.
30. Norder H, Bjerregaard L, Magnius L, Lina B, Aymard M, Chomel JJ. 2003. Sequencing of 'untypable'enteroviruses reveals two new types, EV-77 and EV-78, within human enterovirus type B and substitutions in theBCloop of the VP1 protein for known types. J. Gen. Virol. 84:827-836.
31. Kuethe F, Lindner J, Matschke K, Wenzel JJ, Norja P, Ploetze K, Schaal S, Kamvissi V, Bornstein SR, Schwanebeck U, Modrow S. 2009. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis. Clin. Infect. Dis. 49:1660-1666.
32. Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A. 2003. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 107:857-863.
33. Stille-Siegener M, Heim A, Figulla HR. 1995. Subclassification of dilated cardiomyopathy and interferon treatment. Eur. Heart J. 16:147-149.
34. Kühl U, Pauschinger M, Schwimmbeck PL, Seeberg B, Lober C, Noutsias M, Poller W, Schultheiss H-P. 2003. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107:2793-2798.